A new trading day began on Tuesday, with Applied Therapeutics Inc (NASDAQ: APLT) stock price up 13.86% from the previous day of trading, before settling in for the closing price of $0.22. APLT’s price has ranged from $0.20 to $1.50 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 26.57% over the past five years. Meanwhile, its annual earnings per share averaged 29.93%. With a float of $127.09 million, this company’s outstanding shares have now reached $144.30 million.
Applied Therapeutics Inc (APLT) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Applied Therapeutics Inc is 11.93%, while institutional ownership is 65.69%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.33 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.68% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Here are Applied Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 36.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.10, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.39 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Applied Therapeutics Inc (NASDAQ: APLT) saw its 5-day average volume 6.55 million, a positive change from its year-to-date volume of 5.39 million. As of the previous 9 days, the stock’s Stochastic %D was 39.99%.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 3.59%, which indicates a significant decrease from 40.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0272 in the past 14 days, which was lower than the 0.0860 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7867, while its 200-day Moving Average is $0.5294. Nevertheless, the first resistance level for the watch stands at $0.2667 in the near term. At $0.2828, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.3077. If the price goes on to break the first support level at $0.2257, it is likely to go to the next support level at $0.2008. Assuming the price breaks the second support level, the third support level stands at $0.1847.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
With a market capitalization of 36.15 million, the company has a total of 144,301K Shares Outstanding. Currently, annual sales are 460 K while annual income is -105,620 K. The company’s previous quarter sales were 1,000 K while its latest quarter income was -18,990 K.
